Skip to content

SION SION Preferred Stock, Shares Outstanding

Preferred Stock, Shares Outstanding at other companies

BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$1.86B

Returns & leverage

See full
Return on equity-26.7%
Debt / equity0.0×
Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Questions, answered.

What is SION's preferred stock, shares outstanding?
SION (SION) reported preferred stock, shares outstanding of $0 in Q1 2026.